Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci Mic 🎙️ Exploring Bio.xyz updates 🦠
Recorded: Aug. 7, 2024 Duration: 1:01:09Space Recording
Full Transcription
Thank you. Hi, what's up guys?
It's Leo here from Bayo.
Hey Leo.
Welcome to DSi Mike. We usually give a couple minutes for people to sort of filter in before we get started. We'll get rolling soon. Once again, welcome.
Super. Yeah, sounds great. Perfect. I'll be on standby.
Thanks again for coming in and joining us today on such short notice.
Yeah, anytime, happy to. Thank you. okay um let's get rolling i guess yeah so uh welcome back everyone to another episode of Desai Mike. This week we are joined by Leo
Boltz from BioXYZ.
Definitely one of the
movers and shakers doing
some of the more
interesting things. I think some of the more interesting things.
Certainly there's a lot of really great stuff happening in
the Desai space.
Leo's
going to update us on their
cohort too as well as the upcoming
bio token launch which is really cool to watch as usual I'm joined by co-host Aaron McGinnis
and crypto shrimp PhD who's behind the decide Mike account don't want to spoil too much but
we're also expecting a surprise guest later in the show.
So stay tuned.
Cool, cool.
And I guess I'll get us started here.
This is my first interaction with Leo.
Thanks again for coming on maybe you could kind of explain you know just a quick preview of
how you got into the space and what got you interested in all that yeah yeah
great so yeah basically I've been following the size space since two three
years mainly due to a personal
connection, a personal friendship relationship with Vincent, one of the early initiators
of VitaDAO and core contributors to Bio XYZ from the very early days and like part of
the core team at Molecule.
So yeah, I just got on onto the D-side journey through him, kept watching the
space. And at one point I was sort of seeking, yeah, I was really enjoying what I saw. I had
started to contribute to ValleyDAO just to test the waters to see if the sort of, yeah, the DAO world
and ecosystem could be something for me and then this opportunity came up
to sort of venture into bio xyz and become one of the first people to to to 100 dedicate their time
on um and to kind of um yeah project manage and and um run sort of the end of cohort one and then
uh develop by xyz further for you know new courts to come and and
all that we're building uh at the moment um and so i come with a background of of sort of a variety
of things i'm i'm like a a specialized generous generalist maybe one could say coming with
marketing experience from from a bachelor's program
um sort of business and innovation uh background from a master's program and then having had a couple of like five or six jobs uh mainly in web 2 startups on product and marketing so yeah that's for me as a quick intro to myself. Perfect. Thank you. I guess I know you're a little short
on time, so kind of just to jump into the meat of things. Do you think you could tell us a little
bit about some of the objectives of the second cohort and what you're hoping to build on some
of the successes and maybe even some of the lessons you learned from the first cohort yeah definitely I'd be happy to so I think sort of the the overarching
theme here or a goal is definitely to expand the biodow model onto ideally any sort of life sciences area
or also any disease field if we want to stick to sort of the biotech
and medical realm to see a DAO in any of those disease areas
just because we believe and I think we can see some of the evidence there
that this bio-DAow model definitely is a great
alternative and if not you know sort of a um a better model to the the some of the pitfalls
threat psi brings and so yeah getting the bottom model out there getting people um hyped and
energized on becoming about about our founders and setting up these communities themselves
is definitely the big big objective um i think further down uh we have you know from the past
two years building the space having sort of launched this quite successful first cohort definitely we want to now apply a lot of
the learnings um to the second cohort and kind of redesign and re revamp the the initial program
that obviously also was very like mvp approach right this was the sort of the first first thing
um or first model of like an accelerator approach in this very nascent space and so obviously um
now going into second cohort it we're still early and and still you know it's kind of learning by
doing and on the goal but i think we can we can already drive um drive on to some of the yeah
some of the great things that happened and also some of the kind of um not negative but like
things that didn't work all right uh so so far um so definitely that and then yeah maybe i can
venture into one of the sort of core initiatives that are that is um companion the second the
second cohort and and should really really drive um scalability
into dsci and enabling sort of a dsci 2.0 maybe maybe that's not the best term but scalability
in general because what we've seen um and and kind of dove into the last couple of months or
over the last let's yeah, half year or something
is seeing that the DAOs can, you know, perform or do as great as they are by sourcing so
many projects and getting the right ones funding allocated to but still the space is fundamentally lacking a deeper liquidity
to the projects this is something that investors and capital allocators look at specifically
determining whether or not to get into a project and so enabling a deeper liquidity and thus making these projects and DAOs more fundable and more approachable
is something we identified as a core problem one needs to solve.
And so not only do we now sort of launch a second cohort with ever more bio-DAOs based on new disease fields
and overlooked areas that need that need
um sort of cures for patients we also build this protocol level um sort of liquid layer for dsci
to enable sort of this yeah this flywheel um of of dows getting more funding uh having deeper
liquidity being able to then drive more funding
into projects, and then, yeah, just kind of elevating the space.
And yeah, that's, I'll stop here for a sec, maybe, and allow for some emceeing.
Yeah.
No, yeah, that all sounds great.
So are there particular areas of interest that you guys are hoping to draw attention to?
Or are you kind of looking at anything in the biotech, translational type realm?
Definitely.
So, yeah, I can maybe start by giving a small sort of sneak peek at the pipeline of DAOs we are building at the moment, which is already
pretty cool and like, yeah, very exciting and motivating, motivating me to, to, to go to work,
basically. One of the sort of early admitties to the cohort that we're actually already
collaborating with, and that is basically sort of front front run us almost so to say because um
we didn't you know we we we waited off for launching the second cohort um to get a little
bit of time to work on the program and also build on this protocol initiative that I just mentioned
on but Cerebrum DAO and we are joined by Mark um Mark one of the court core members of Cerebrum
DAO he's here with us maybe you can you can also tap in in a second but of CerebrumDAO, he's here with us. Maybe you can also tap in in a second.
But basically CerebrumDAO is just kind of outpacing the space and doing insane work
on advancing neurodegenerative diseases and that space in general.
So they are an early participant of core two um which is
yet to launch although cerebrum dollars already launched so they're just doing great work um
congratulations and a big shout out to the to the team at cerebrum dow you should definitely check
them out um and yeah uh alongside cerebrum dow we are looking uh and already also kind of locked in
we are looking and already also kind of locked in with another neuro neuroscience
DAO which is called synapse DAO by former or also I think current chief scientific
officer of Novartis in Switzerland this is also a really cool team that is
building sort of in a similar space yet um with a little bit different different of focus and then yeah we
have uh we are in the talks with sort of um dows in in the domains of quantum biology rare diseases
um long covet or covet as a um in general as a disease space and so these are just to name a few
that are kind of you know filling filling
the pipeline or that are in conversation and we furthermore actually very recently i think just a
couple days ago um published a um an article on our blog which i'm happy to kind of refer to you
you guys to um or actually never mind this is not not a blog article yet but it was actually a tweet
coming from our our bikes with the twitter um sort of softly announcing a call for for applications
and maybe i can just highlight two or three um areas we're we're definitely excited for to see
among a lot of them um but one of them being adhd and nootropics which we yeah which kind of um
we thought to to batch together um just seeing that sort of there's a yeah um
a big need for for cures in that domain sleep being another one um you know we see kind of insomnia for for example as a a yeah being experienced by a
significant um fraction of the population um so that for sure then nutrition and obesity would
be another area but then you could you could just stack you know you could stack multiple on top. We want to see DAOs and rare diseases, immunology, oncology, cardiology.
Yeah, just to name a few. Cool. Well, yeah, I'm excited to definitely hear from Mark, but I know
you had a stop time at 1020. So with the last five minutes, I did kind of want to kind of explore,
you know, any sort of,
if you could walk us through, you know, what the process of applying for cohort two and any sort of
dates that we need to keep in mind or things like that.
Yeah, cool. I'll keep it short there. So there so to be honest there's not there's not a specific time frame yet i want to i want to um
sort of get nailed down on we're still developing that framework and there are some some loose ends
ends we're tying up but you can expect to hear communication around that um rather soon within
the next couple of weeks um to give us sort of a very rough overview,
we're definitely expecting to launch cohort two this year in the fall
or sort of, yeah, fall, end of fall.
And thus, yeah, the call for applications
and an increased campaign around that
and talking to folks will start very soon.
Cool.
Well, that actually went a little quicker than I was expecting.
So we have a little bit more time.
Can you maybe touch on a little bit about what sort of resources
some of these selected DAOs will receive once they're part of the cohort
and maybe how long the cohort lasts or
what would happen in the cohort, some details like that.
Yeah, for sure. So essentially we have sort of quite the 360 degree approach,
360 degree approach basically from from inception to launch the whole user
journey of being a DAO founder is we accompany we accompany and so this
starts at you know setting up sort of your your legal railings and and
foundation so legal setup for you know for the best setup of your your legal railings and and um foundation um so legal setup for you know for
the best setup of your dao will be included uh looking at sort of your visual um identity
so you know some of the core thing for for any project obviously is uh the way you you represent
and the way you uh come across to to to new joiners
and how you position yourself and so messaging brand building and a website is definitely is
as part of the service package and then so and those are kind of the baseline things and then
we start looking together in like you know know, guided sessions, workshops and whatnot,
at sort of the, you know, the main DAO strategy, looking, locking in sort of your scientific and R&D approach,
strengthening the approach of how to engage with universities, set up these agreements and fund you know or sort of you do the right due
diligence and then fund essentially fund um essentially fund projects talking about how next
to this funding funding mechanism you can also start thinking about sort of productizing uh
within your dow and other means this is like a good example, actually sparking with Cerebrum DAO there.
They just initiated sort of this product working group
where they're looking at other means
of sort of generating revenue
and proceeds for the DAO treasury
alongside the funding mechanism of funding research,
building community, alongside the funding mechanism or funding research.
Building community, getting set up in the Web3 world, all of these things,
they were not necessarily in the order I just mentioned them,
but I just wanted to drop a couple of the items
that you can foresee in the program.
So yeah, lots of ground to cover.
That's great.
That sounds like lots of help and lots of lots of ground to cover that's great that sounds like you know lots lots of
help and lots of resources a great community be a part of um for anyone interested i did drop the
the buyer protocol thread uh under under the chat here in the comments so that you could get to i
think there was a link for the applications there but but I'm not entirely certain, but that would be the right account to follow and all that.
You know, just to be conscious of your time.
You know, I know we have a minute left.
Is there anything you'd like to leave us with or share before you have to go?
Yeah, all good.
I wanted to actually maybe tap on into one more thing that I think is a cool note to leave you guys on, something I'm also looking forward to, which essentially is going to be brought by the new bio protocol that we are installing and building right now.
And so essentially, some of the components that we in the first cohort did quite manually, for example, setting up your token contract for your DAO and creating a first fundraising mechanism and more things will sort of be automated by the bio protocol and allow for you know
very streamlined and quick automated sort of DAO creation in a lot of senses what will kind of
kind of fall into this is now not only we as sort of this BioCore team looking at the applications that come in, but we want to extend this and kind of decentralize the whole process of looking at applicants and sort of have the Bio community, the Bio token holder, which there will be, which will come into effect soon as we're gearing up for our token launch starting tomorrow, actually.
So, yeah, dropping this information here as well. effect soon as we as we're gearing up for our token launch uh starting tomorrow actually so
yeah dropping this information here as well um essentially the bio bio token holder community
will be curating will be able to curate um the best decide house out there staking their their
their their community governance token towards the one the dows they want to see funded right and so
governance token towards the DAOs they want to see funded, right?
And so those stakers will then have sort of whitelisted private access to first funding
rounds of BioDAOs and all of these sort of features and concepts we're thinking of and
we're thinking of and planting into the new protocol,
planting into the new protocol, which I'm very excited about.
which I'm very excited about.
And hopefully, yeah, all of this, you know,
brings Desire to the next level, you know,
allows for more adopters and people to flock into the space.
And yeah, that's it from sort of a feature tease
of what's to come with the protocol.
And yeah, maybe last but not least for those of you
who are you know are not maybe falling that closely and had heard have heard of bio xyz and
the bio protocol etc for the first time tomorrow actually marks the day where we sort of do our
token generation event the we call it the BioGenesis event in which you can swap
certain tokens to get bio.
This is the first and only time
to get your hands on bio
which is non-transferable
at the beginning and pending a community vote
will become transferable and liquid
and posted to the open market
basically later this year.
Stay tuned and follow us on on
twitter uh and definitely make sure to to to not miss out on this event if not investing advice
obviously but if you're keen and and you enjoy the space um definitely look out tomorrow for for for
this for the swap launch um and yeah, follow us on Twitter and the website
to learn about how to participate and whatnot.
Yeah, giving it back to you.
Thanks for joining us
and thanks for the massive alpha drop.
Really appreciate it.
Yeah, definitely.
Anytime.
Okay, so... Cool. Yeah, okay. Well well we're also joined by uh mark from uh cerebrum dow um you
know and um to maybe to continue the uh tradition of dropping alpha in in you know in in the d side
mike um you know mark maybe you could tell us a little bit about
um the work cerebrum does doing uh your your brain health survey um anything else that's on your mind
cool thanks very much for having me on i think yeah as leo introduced cerebrum was in the past cohort with Bio, and we really wanted to establish an organization which is
setting up funding, looking at addressing translational gap for bringing
new therapies, new interventions from research into the product space. And I've also been
establishing a product group,
which is really focused on the near-term solutions.
So for example, bringing out things
like apps to help you track your brain health and brain
focus over time, laying the foundation
for collecting longitudinal data from individual users,
which can then be eventually added to our understanding of
how brain health is changing over time and then i believe these things will come together as well
with other decentralized science tools uh conducting trials also potentially within the
doubt community to really accelerate how we're addressing brain health. So this is really a large part of the roadmap strategy
right now for Cerebrum, to have a deal flow process,
which is addressing the longer term interventions
and pharmacological interventions that we can develop
and accelerate and do it alongside revenue
and also engagement generating opportunities
in the product space, whether that's brain health assessment, stimulation of the brain using non
invasive techniques or supplements and really giving like empowering people
within the DAO to have more agency over their brain health as they're aging and
to really participate in the generation of new interventions and part of of this, we're doing a brain health survey,
which is also understanding better what people are looking
for and how they view brain health right now
in terms of supplements and interventions on the market
and really looking to engage people
in this creation of new brain health solutions for them.
in this creation of new brain health solutions for them.
And we're happy to hear feedback on that.
I'm also happy to talk more about some of the ideas
that we have for decentralized science going forward.
Also with large language model integration
integration with the data that's being created within the DAO.
with the data that's being created within the DAO.
I would love to get into that. Before we do, I would love to hear maybe just a quick little bit about your experience going through cohort one.
Maybe some of your takeaways uh some stuff like that oh definitely so i also had to give a bit
of a preference i was in some other dsci projects uh before coming to cerebrum uh and one of the big
honestly i think one of the great things of the bio experience about xyz launchpad and now the
protocol is i guess echoing what Leo was talking about where
traditionally when I was getting into these DSi projects or DAO projects it was a bit unclear
what exactly is a DAO, what does it mean to launch a token, what are all the mechanics
required to do governance setup, compensation setup. So there's so many pipeline mechanics
So there's so many pipeline mechanics, which we were,
yeah, they're unclear on or not, you know,
it's unclear if you have to build this yourself
or if you can take it on from other developers.
Also the legal structure, you know,
there are a lot of DAOs which have a legal foundation
in Switzerland, and that's really forming the legal basis
for the organization. So it's not just a crypto organization completely existing only in the digital space,
but it's got a physical grounding.
And that was actually one of the things that was unclear when I was working on some earlier
DAO projects, like how do we actually launch an organization which has a legal basis, which
can be invested in? How do we actually launch an organization which has a legal basis, which can be invested in?
How do we launch a token? And so I think one of the advantages is that we could
allow bio to really take over a lot of that stuff. The bio launchpad, I think,
really served that purpose to help facilitate the launch of the token without us having to put
all the resources that would have been required, otherwise really build a lot of the token without us having to put all the resources that would
have been required otherwise to really build a lot of the stuff from the ground up. And I believe
going forward, you know, after doing the first cohort and going into the second cohort and people
see that these are real projects that are being launched that are then generating value for society
and for the DAO members, I hope that will really flow into the
whole bioprotocol story where we see that, hey, if we put more liquidity into these science projects,
we're going to be doing good for the world. And I'd like to see the point where it becomes more
of a self-perpetuating organism and mechanism, right? This really goes in line with decentralized data collection,
large language models where we get towards decentralized scientists, which are, you know,
really will probably be protocols within themselves. So I see this, you know, the biogenesis
position of the foundation that was established, I would say, over the past couple of years and
really interested to see how it can develop
to really accelerate science for good throughout the world.
Cool. That's great.
Yeah, I'd love to.
You mentioned a little bit about, you know,
what Cerebrum is doing with AI and large language models.
I'd love to hear a little bit more about what you're doing with that,
as well as how you're actively either doing it
or hoping to build some of these blockchain technologies into the DAO.
So I think going forward, a lot of the DAOs are first focused on funding projects.
But then as we
start to move into more solution development and product development, it means we're generating
data. Also with a lot of the DAOs, in particular, we have a large scientific basis for the DAO
numbers. So, you know, we're all interested in how do we build new solution pathways? How do we
accelerate the development
that we're doing there's a lot of forces that i think are coming together over the next
couple of years number one is the foundational model development for different entities of
in science so for example you have nvidia was just releasing more publicly their ability to
have a foundational model to look at what proteins might be binding
to which targets in a drug development process. There's foundational models being developed for
neurotechnology, either based on brain-computer interfaces like EEG, or by essentially scraping
a lot of abstracts in the neuroscience literature and looking at how we can predict what will be
created next. So that's in the brain GPT model, I believe. So what I'm looking at is how is
Cerebrum going to be connecting with these different models. A big part of it I see is
our own internal data collection, which can be going to training foundational models for brain health and so
really understanding how different interventions can be personalized for users based on what's
available to us and then also helping to feed in with the pharmacological development for you know
what can be developed and what should be funded so i i'm imagining this future where each bio DAO has
their own LLM, their own domain knowledge,
their own knowledge graph, and their own API.
And this is where it gets super interesting,
because if you imagine that we have liquidity going
into the decentralized science community,
when we now see a project which might be a crossing
between different DAOs, like it's a neuroscience DAO and it's a cardiac DAO. Maybe this is a point where
the protocol automatically allows us to start funding solutions or researchers so that this
is not just a situation where each DAO first takes in a project and then they go through an
evaluation process which is very labor intensive, very science intensive.
And it actually in some ways limits us because we're still humans that are doing this evaluation process.
And what I want to see is this future where we have AI agents together with the large language models,
together with the domain knowledge of all these different individual DAOs,
together with the liquidity that's being hopefully unlocked through the Bauer protocol, I see these forces come together to then
accelerate how we're developing new solutions based on the data that we have. So when I think
about the value of a dSciDAO, I'm really thinking about the long-term knowledge graph value that each
dSciDAO can bring and contribute to the world.
The funding is really an important part of it, but I see it as like the stepping stone to getting to that point where we are really enabling science almost on an automatic process,
but still being directed by the needs of humans so that we're not just creating AI agents on chain or off chain that are
you know just acting out of chaos but acting out of the need to fulfill the
purpose of each DAO whether it's neurodegeneration or cardiac health or
brain health or mental health and I think the community through bio protocol
you know and the the way that things are being
created on the same platform can help to, let's say, bring a foundation to it, right?
So I don't want to be in a situation where there's different DAOs that are being created
to compete with one another, you know, to rule the D-Sci space for neuro health
or for cardiac health,
but that we are creating DOWs which are decentralized,
that can scale and work together
so that we're co-creating, you know, the science future
and not just competing with one another,
which I think also kind of gives an idea
to how
D-side DAOs' organizations differ from, for example, startup companies.
And that's also really important to think about.
Like, why are we getting into DAOs?
Why should we be launching DAOs?
How do they work within the current economic system that we've developed,
where you have large pharma corporations you have small startups that are um you know probably working on different pharmacological interventions and
de-risking them before they can be taken over by large pharma companies i'm really interested to
see how we can build the d-side dows as this force within the rest of our science ecosystem
um to really accelerate the new solution development.
Really love to hear that vision, Marcus. That's very exciting because I think that
what you're saying, you know, I think gives DSi hope in addressing one of, I think, the main
criticisms of so-called TradSci, which is like, you know, you alluded to this with your when you mentioned startups, right, which is like information and science tends to be kind of like far too siloed.
Right. And, you know, it sort of prevents innovation at the intersection of you know a lot of different research work
yeah i think to you know i think organizations serve different purposes at different points in
time like i like i've worked in academia as a postdoc i've worked in corporate research and
automotive and then i've been working in startups and now also decentralized science.
And, you know, I think they all have their advantages.
And it's just a question of what we need at what point in time to accelerate stuff.
And I don't, you know, I also don't think that traditional science is like completely broken.
I also don't think that traditional science
is like completely broken.
I think we're just trying to find ways
with DSI projects and crypto
to accelerate resource sharing, liquidity,
and also really understanding
what problems should we be solving
and where should we be putting funding
at this point in time to solve the problems
that we have now and the ones that are coming up
in the future. And I think that the shared knowledge graphs that we'll be creating is going to be one
of the glues and one of the ways to really accelerate that.
I couldn't agree more. I think one of the things I'm most excited about DSi is, you know, above and beyond funding and publishing and all that, but the ability to share information much quicker than it currently exists in the industry right now.
the industry right now. Yeah, and that's also why I think the types of D-side DAOs that are coming
up is so important because you have some that are addressing the problem of publishing. You have
others that are going to be addressing data collection and storage and creating decentralized
trials with correct anonymous data protections. And traditionally, these are things that are also solved
individually by individual companies.
But we might be able to be a bit more fluid and a bit faster
with DSi kind of creating this foundation.
And then other organizations, of course,
are also going to be participating in them.
I think it makes sense that just as you
have innovation arms of large companies like Takeda or Roche,
who already work with startups, that we can interface with them to also work with decentralized science organizations.
So I'm really interested to see how these conversations with these stakeholders are also evolved over the next couple of years. Because I think we're all, you know,
working towards the same goal of a better future
and a better place for humanity.
And it's just a question of how different people
have different motivations to focus on different problems.
So, yeah, I think it'll be a way to bring together everything
and hopefully move things forward in a more systematic way.
I have a more sort of like, if you'll indulge me, a more sort of general philosophical question.
philosophical question.
You know, I mean, given your, I think, unique experience
and having, you know, worked in like academic science,
corporate science, and now DSI,
what do you think are like the top opportunities for DSI?
Like what are you kind of doing now that couldn't be done
within like academia or, you academia or the corporate space?
And what are the challenges of working with DSi?
So I think the advantage is that we focus first on the global problem.
So like a lot of the DSi work that I'm working on now,
it's actually a lot of it is coming out of the early projects
that I was doing with the Foresight Institute and people like Marina Pagliakova who are working on
technology trees for neurotech and neuroscience. And our goal there was to map out a field
and then say what thread we should go down when we want to solve neurodegeneration. So that's happening outside of the traditional way
that you pitch a translational project, right?
Because normally, you would be a postdoc or a PhD student.
You have a technology that is really interesting,
some sort of scientific discovery.
You want to then turn it into a company.
Then you have to take a step back.
You learn about a business model canvas.
You learn about solving a person's problem or an industry's problem, and then you have to create a
product out of that. And that's where I think it becomes very difficult because there are many
scientists who just want to be scientists. They don't want to be CEOs. They don't want to be CTOs
for an organization. So I think the DSI is an interesting
structure which allows you to do the science, find the solution, and then facilitate that
translation of the solution into the product space. A lot of DAOs are also working essentially
as venture builders. So not just investing in in IP but investing in the companies that are being created and trying to use the knowledge base of
the Dow to facilitate that if you compare that to something like venture capital for example
the venture capitalist firm is you generally have a fund and
Then you do your research you look at what people and what companies to invest in,
but you're not building your own products.
And also startups are generally working
to solve one problem,
bring one product out to the market,
which is going to change the world.
And I like the idea that the D-Side DAO
can basically fulfill both goals within one organization and that's something which
uh i would say i didn't really feel like i had in different experiences so you know when i was
working in research the focus was always on you know publishing right because that's your economy
you publish more papers you get more funding or you get more grants. If you publish patents, it doesn't matter that much because that doesn't give you value as a scientist in a lot of organizations.
And then working in a startup is really great, but many times you have the larger vision that you want to make happen,
where you know it's going to be valuable, but you don't know how to monetize it.
And then you have to go back, think about product development,
think about the business model.
And so I love the idea that in the D-side-Dows,
because these are networked organizations,
you're going to have the product people,
you're going to have the investment people,
you're going to have the scientists all in one area so that i believe
we can really allow people to do their best work and their best personality you know for who they
are and i think that's going to make it more efficient to translate science to products and
innovations for the world because you don't have to you know take on the role of being a manager if you're not a
manager right the the goals that we have with the daos is that you can come in as a person that you
are you fill in the right piece of the dow and you don't have to be working full-time uh you contribute
the amount that you need to contribute to bring value to the organization. So I feel like that's
probably one of the biggest differences. I mean, to me, I never really thought too much about it,
but I guess your question kind of sparked this train of thoughts. So
I'm not sure if that made full sense. No, no, that was fantastic insight, actually. Thanks.
You have a very unique perspective, in my opinion.
Not to cut you off, did you have any more to add there?
You know, I mean, I could talk for a while,
but I think that probably encapsulates it.
Okay.
Yeah.
Fair enough.
Aaron, did you have any questions for Mark?
Also, anyone from the audience, if you want to raise your how this will be able to allow more people interested in
their own brain or brains as kind of a collective thing we can study and engage with
and being able to participate in that in more meaningful ways. And everything going on with
the product working group is super exciting.
I know one of the main focuses right now is that brain health survey and getting that out to more people.
Are there, is that really open for everyone to fill out? Are there specific types of people you're particularly looking for to
help contribute into that knowledge base? So it originally started as a way to evaluate how
people are looking at brain health supplements and how they're tracking data. We're pretty open
to just having a survey taken by everybody who's interested in brain health we're considering to
create a more a larger more in-depth survey of brain health in the future but there's also a lot
of other research organizations that are also completing some pretty large brain health studies
and i think the results will probably be published by the the end of the year. So this is first just to bring more engagement to the DAO and to really,
you know, extend the conversation, like what is brain health? How can we affect it in this
period of time? And for the people who are also then interested in contributing, then bringing
them on into the organization. So yeah, I'd be very happy to have it shared widely as much as possible.
But we're definitely interested in potentially developing some other more in-depth surveys
in the future along with our product developments.
Are there any, I guess, survey type questions or focus areas that maybe the group has talked about
or you're personally curious about and think Cerebral McDow can help kind of fill in in
investigating those questions?
Any top topics come to mind?
Well, the main question is, you you know do we believe that our brain
health is something which is set and which hits a point and then degenerates
and we don't have anything to do about it so it goes very in parallel to the
concepts of longevity I think and looking to see how people feel about
their ability to affect their brain health through
non-invasive interventions, whether it's supplements that are being reviewed in the medical literature,
exercise, lifestyle changes. Now we're really trying to gauge how well people are open or
accepting of managing their brain health with some different digital
tools and supplements and interventions and if we you know as we understand the
answers to some of these questions that helps us to then build out the
requirements before our product roadmap going forward you know we have a lot of
assumptions and ideas about how people would need or want
different products such as personalized language models that are working with their brain data
to help them track out and do the interventions that are needed to improve their personal
focus and brain health over over their lifetime.
So we're really using this as a way to craft and create the trajectory for the for the products that we're developing and bringing out and also the the partnerships for our products that we
want to bring to the DAO community because we also see this future for bringing in staking mechanisms with the Neuron token as a way to help people get interventions
and products at a reduced cost and discount.
So we're looking at how the token can be a way for governance within the DAO,
as well as facilitating access to products and interventions going forward.
Amazing. That's one thing I'm really excited by that is happening in the DSI space is being able
to take some of this different knowledge or support in the creation of knowledge to then
help each of us or people we care about from kind of a health perspective or from kind of a broader
environmental perspective as well. These are all super exciting updates and I think there's a lot
some of the new bio DAOs might be able to learn from your guys' approach. I guess tying it back to some of the beginning
conversation around BioDAO and BioXYZ, some of the support there. You guys have launched your
token already, have a well-functioning DAO, in my opinion at least, and are there any lessons
that come to mind that you might have learned along the way that others who might have ideas for bio DAOs might want to keep in mind as they might start pursuing that?
Definitely. I think, you know, one of the most important things is to understand and agree upon the purpose of your DAO,
because that's really informing the
backbone of the people they are bringing in, why the people are getting involved, the time
commitments that they will bring into the organization. And if you're not sure what
problem you want to solve or what you want to do for the world, that's going to be more difficult.
Now you can figure this out, right?
There's a lot of different design tools that you can use,
strategy tools, workshops that can be undertaken.
And there's a lot of people who have gone through this process already,
whether in an organization like Cerebrum or VidaDAO,
who are also open to giving feedback
and helping people.
Like I was getting an email the other day
from a person who is interested in potentially creating
a DAO around brain cancers.
So, you know, we'll sit down,
we'll have a meeting for Friday to talk together
and start to help I can get help give some perspective on next steps for them going forward.
So I think definitely the purpose and then also the roles and responsibilities of the core team.
Because it's really important, especially in a decentralized organization, to understand
who is doing what and basically who's responsible for what. and that's going to be true of any
organization or company but I think it's especially important with
decentralized DAOs that are maybe existing primarily on discord or other
online platforms because you need to have the roadmap going forward understand
you know what are we doing this week, next week, over
the next month. Not in an exact project detail, but understanding that you're all moving towards
the same purpose and are there for that shared vision. So I think if you have that as a foundation,
then it's going to be easier to understand what organizations you're building,
what other people you need to bring into the organization,
whether it's advisors or people who might be product people or project managers.
Because any organization, you're going to have to design what's needed to achieve your goals.
So I think some of that very basic stuff like team building is really important to think about and do in the early stages.
And then when you have that story,
that vision,
then I think it makes sense to,
if you wanted to launch a token
and do it through bio or another platform,
that you already understand
why you're there
and what you want to do and
how to go forward. So if you have that foundation, I think the rest of it will
be easier and fall into place. And that's always what I talk about. Also, if I'm at a conference
giving a talk, that the DAO purpose is really one of the most important things to really think
about mission and vision.
And then the details, the technologies
you need to use to get there, the processes
you'll need to set up, those will logically flow
from that mission and vision.
And yeah, I encourage people to start with that first,
and then start to fill out the rest of the organization.
Definitely, that's really solid advice. I know that definitely
falls in line with some of the research we had done at TalentDAO, researching DAOs and leadership
and successful DAOs learned or copied a lot of the strategies of startups in general of getting clear on
what they're focused on and making sure some of these structures are in place to move forward
effectively towards their individual goals within the DAO. So really appreciate you sharing some of
those learnings. For anyone listening in, we do have a couple more minutes.
If you have any questions for Mark as well, either on CerebrumDao, Brain Health, BioXYZ, he's a great resource on that front as well.
So if you have any questions, feel free to raise your hand, request the mic, or leave a comment down below, and we can read those off.
While we're waiting to check for that, Mark, did you have any closing thoughts throughout the
whole conversation today or anything else that might be top of mind, maybe from a Sri Broomdow perspective, Desai perspective overall.
We have one person who came up to request to speak, so we'll jump into that. Then I would
love to hear some closing thoughts from you, Mark. Fate, if you're able to speak, would love for you
to happen. Hey, Erin. Thanks for letting me up and appreciate y'all hosting this space.
So one question, I guess it wasn't very clear to me.
What is the relationship between the bio token that's launching tomorrow and then Cerebrum because I thought that earlier in the space, Leo or sorry, was his name Leo?
Had said that
you would be able
to use the bio token
to basically stake
it and kind of
decide in the next cohort
what projects you would be
supporting with your bio tokens
with your vested bio tokens.
But I kind of missed the relationship between Cerebrum DAO and bio, if there is one.
Yes, so Cerebrum was one of the bio DAOs launched within bio XYZ.
When they do the token Genesis event, essentially there's a collection of bio DAOs that have launched from the bio protocol.
If you're holding one of those tokens, then you can swap it for bio.
So it's a way to basically engage the larger DSI community who are already working on these projects to be holders of the BIO token.
I believe then what will happen later on, there will be a governance decision
to allow BIO to be openly traded on other platforms.
And that will start allowing more people to be involved in holding the token.
more people to be involved in holding the token. And then after that we're going to set up token
utility. And one of the token utilities I believe will be staking the token so that when they're
also launching or considering which projects to launch in future cohorts, that the token can be a type of voting mechanism
for governing which DAOs, which new DAOs are being created.
Got it. Okay. So at the moment, there is a Cerebrum DAO token, right?
Yes, we have the Neuron token, which was launched end of April of this year.
Got it. Okay. Okay, cool. No, yeah. I appreciate it. The answers. Thank you.
You're very welcome.
Yeah, there is a super exciting ecosystem blossoming there. And I think we'll continue
to see that growing out with cohort two, bio dao sprouting up and that also creates
more cool ways to engage in the entire dsci ecosystem uh so yeah mark hopping back over to
you for any closing thoughts um um the conversations free broom dao dsci overall The conversations, FreeBroomDAO, Desai overall, Brain Hill.
Yes, thank you.
Well, I would say I'll reach back to the time we met.
We met in Tokyo.
Me and Aaron were at the Desai Tokyo conference.
And back then, a lot of these things were ideas.
Architecture that we could build, ideas that we wanted to build into DAOs.
At least for me personally, I think it's been a huge jump from that year to this year. The DAOs have been created,
the work that we're doing and defining our strategy and structure, deal flow processes,
products going forward. So I'm really excited, I mean, to be closing, starting to get into the end of this year this year the fourth quarter and thinking about what we're going to be building
next year as all these different technologies that are also going to be
coming into the the building space through AI agents large language models
foundational models liquidity and the DCI community and all the other things
that people want to build in the future, like wet labs that are being controlled by AI agents, which maybe could be controlled also by decisions from the bio protocol.
I think there's, I'm feeling pretty positive about the DCI future.
So in closing, I'll just say that, yeah, looking forward to building, interacting with more people and helping to facilitate new DAO projects being created and
launching. Thank you. Absolutely. Awesome. For everyone listening in, definitely go follow along
with Mark. Whenever he's at different conferences, he always posts some really wonderful recaps of all of the presentations and conversations going on.
So definitely follow him at minimum for all these updates on what's happening in the DeSci ecosystem and other adjacently connected conferences too.
Check out SreebrumDow, all the cool stuff they're up to, BioXYZ, and get ready for their Genesis launch.
I think those were some of the main things to show.
If you haven't taken the brain health survey, definitely go take that and participate in this whole conversation in that type of way. And then we'll see you back here
next week, same time, 4 p.m. UTC Wednesdays with another new conversation. If you have a topic or
theme you'd like us to dive into, reach out to any of the co-hosts up here, Merrick, myself,
reach out to any of the co-hosts up here, Merrick, myself, or D-Sign Mike or Crypto Shrimp,
and we'll be able to get that topic on the agenda.
In the meantime, have a great week.
Thanks so much for joining in.
Thank you. Have a great week.
